{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:55:37Z","timestamp":1792047337487,"version":"4.4.0"},"reference-count":234,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Acetylsalicylic acid or aspirin is the most commonly used drug in the world and is taken daily by millions of people. There is increasing evidence that chronic administration of low-dose aspirin of about 75\u2013100 mg\/day can cause iron deficiency anaemia (IDA) in the absence of major gastric bleeding; this is found in a large number of about 20% otherwise healthy elderly (&gt;65 years) individuals. The mechanisms of the cause of IDA in this category of individuals are still largely unknown. Evidence is presented suggesting that a likely cause of IDA in this category of aspirin users is the chelation activity and increased excretion of iron caused by aspirin chelating metabolites (ACMs). It is estimated that 90% of oral aspirin is metabolized into about 70% of the ACMs salicyluric acid, salicylic acid, 2,5-dihydroxybenzoic acid, and 2,3-dihydroxybenzoic acid. All ACMs have a high affinity for binding iron and ability to mobilize iron from different iron pools, causing an overall net increase in iron excretion and altering iron balance. Interestingly, 2,3-dihydroxybenzoic acid has been previously tested in iron-loaded thalassaemia patients, leading to substantial increases in iron excretion. The daily administration of low-dose aspirin for long-term periods is likely to enhance the overall iron excretion in small increments each time due to the combined iron mobilization effect of the ACM. In particular, IDA is likely to occur mainly in populations such as elderly vegetarian adults with meals low in iron content. Furthermore, IDA may be exacerbated by the combinations of ACM with other dietary components, which can prevent iron absorption and enhance iron excretion. Overall, aspirin is acting as a chelating pro-drug similar to dexrazoxane, and the ACM as combination chelation therapy. Iron balance, pharmacological, and other studies on the interaction of iron and aspirin, as well as ACM, are likely to shed more light on the mechanism of IDA. Similar mechanisms of iron chelation through ACM may also be implicated in patient improvements observed in cancer, neurodegenerative, and other disease categories when treated long-term with daily aspirin. In particular, the role of aspirin and ACM in iron metabolism and free radical pathology includes ferroptosis, and may identify other missing links in the therapeutic effects of aspirin in many more diseases. It is suggested that aspirin is the first non-chelating drug described to cause IDA through its ACM metabolites. The therapeutic, pharmacological, toxicological and other implications of aspirin are incomplete without taking into consideration the iron binding and other effects of the ACM.<\/jats:p>","DOI":"10.3390\/ijms25105150","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:16:45Z","timestamp":1715231805000},"page":"5150","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Puzzle of Aspirin and Iron Deficiency: The Vital Missing Link of the Iron-Chelating Metabolites"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-7340","authenticated-orcid":false,"given":"George J.","family":"Kontoghiorghes","sequence":"first","affiliation":[{"name":"Postgraduate Research Institute of Science, Technology, Environment and Medicine, Limassol 3021, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02829934","article-title":"A precious metal: Iron, an essential nutrient for all cells","volume":"1","author":"Cairo","year":"2006","journal-title":"Genes Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gozzelino, R., and Arosio, P. (2016). Iron Homeostasis in Health and Disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010130"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1559S","DOI":"10.3945\/ajcn.117.155804","article-title":"Current understanding of iron homeostasis","volume":"106","author":"Anderson","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOH.0000000000000132","article-title":"New insights into iron regulation and erythropoiesis","volume":"22","author":"Kim","year":"2015","journal-title":"Curr. Opin. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360701713104","article-title":"Oxidative stress and iron homeostasis: Mechanistic and health aspects","volume":"45","author":"Galaris","year":"2008","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","article-title":"Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases","volume":"1863","author":"Nakamura","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J., and Kontoghiorghe, C.N. (2020). Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases. Cells, 9.","DOI":"10.3390\/cells9061456"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.2174\/092986705774462969","article-title":"Structure\/function overview of proteins involved in iron storage and transport","volume":"12","author":"Sargent","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1258\/0007142991902628","article-title":"Inborn errors of metabolism: Iron","volume":"55","author":"Worwood","year":"1999","journal-title":"Br. Med. Bull."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1017\/S1368980008002401","article-title":"Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System 1993\u20132005","volume":"12","author":"McLean","year":"2009","journal-title":"Public Health Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"key":"ref_12","unstructured":"(1983). Community control of hereditary anaemias: Memorandum from a WHO meeting. Bull. World Health Org., 61, 63\u201380."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tardy, A.L., Pouteau, E., Marquez, D., Yilmaz, C., and Scholey, A. (2020). Vitamins and Minerals for Energy, Fatigue and Cognition: A Narrative Review of the Biochemical and Clinical Evidence. Nutrients, 12.","DOI":"10.3390\/nu12010228"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2174\/092986705774463030","article-title":"Molecular factors and mechanisms affecting iron and other metal excretion or absorption in health and disease. The role of natural and synthetic chelators","volume":"12","author":"Kontoghiorghes","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"ref_15","unstructured":"Moustarah, F., and Daley, S.F. (2024). StatPearls, StatPearls Publishing."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Barton, J.C., and Edwards, C.Q. (2000). Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment, Cambridge University Press.","DOI":"10.1017\/CBO9780511666476"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ijlh.12347","article-title":"Epidemiology and diagnostic testing for hemochromatosis and iron overload","volume":"37","author":"Adams","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosis\u2014A new look at an old disease","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis","volume":"13","author":"Feder","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2004.02024.x","article-title":"Targeted screening for hereditary haemochromatosis in high-risk groups","volume":"20","author":"Dubois","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5662\/wjm.v4.i4.197","article-title":"Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases","volume":"4","author":"Kolnagou","year":"2014","journal-title":"World J. Methodol."},{"key":"ref_22","unstructured":"Modell, B., and Berdoukas, V. (1984). The Clinical Approach to Thalassaemia, Grune and Stratton."},{"key":"ref_23","first-page":"704","article-title":"Inherited haemoglobin disorders: An increasing global health problem","volume":"79","author":"Weatherall","year":"2001","journal-title":"Bull. World Health Organ."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/bjh.18671","article-title":"Thalassaemia\u2014A global view","volume":"201","author":"Hokland","year":"2023","journal-title":"Br. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","article-title":"Survival and causes of death in thalassaemia major","volume":"2","author":"Zurlo","year":"1989","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00421-019-04157-y","article-title":"Iron considerations for the athlete: A narrative review","volume":"119","author":"Sim","year":"2019","journal-title":"Eur. J. Appl. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/trf.12647","article-title":"Iron deficiency in blood donors: A national cross-sectional study","volume":"54","author":"Salvin","year":"2014","journal-title":"Transfusion"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/157339631130900008","article-title":"Is red meat required for the prevention of iron deficiency among children and adolescents?","volume":"10","author":"Savva","year":"2014","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mantadakis, E., Chatzimichael, E., and Zikidou, P. (2020). Iron Deficiency Anemia in Children Residing in High and Low-Income Countries: Risk Factors, Prevention, Diagnosis and Therapy. Mediterr. J. Hematol. Infect. Dis., 12.","DOI":"10.4084\/mjhid.2020.041"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wessells, K.R., Young, R.R., Ferguson, E.L., Ou\u00e9draogo, C.T., Faye, M.T., and Hess, S.Y. (2019). Assessment of Dietary Intake and Nutrient Gaps, and Development of Food-Based Recommendations, Among Pregnant and Lactating Women in Zinder, Niger: An Optifood Linear Programming Analysis. Nutrients, 11.","DOI":"10.3390\/nu11010072"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4103\/jfmpc.jfmpc_1062_19","article-title":"Prevalence of anaemia and its association with dietary habits among pregnant women in the urban area of Haryana","volume":"9","author":"Grover","year":"2020","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2174\/1389450119666180605112235","article-title":"Pathological Roles of Iron in Cardiovascular Disease","volume":"19","author":"Kobayashi","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"ref_33","first-page":"365","article-title":"Knowledge, Attitude and Practice towards Dietary Iron among Patients with Thalassemia and Their Caregivers in Peninsular Malaysia","volume":"74","author":"Man","year":"2019","journal-title":"Med. J. Malays"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3945\/ajcn.117.156034","article-title":"Dietary Iron Intake, Iron Status, and Gestational Diabetes","volume":"106","author":"Zhang","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Milman, N.T. (2020). A Review of Nutrients and Compounds, Which Promote or Inhibit Intestinal Iron Absorption: Making a Platform for Dietary Measures That Can Reduce Iron Uptake in Patients with Genetic Haemochromatosis. J. Nutr. Metab., 2020.","DOI":"10.1155\/2020\/7373498"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/1745039X.2015.1057065","article-title":"Effects of polyphenol-rich plant products from grape or hop as feed supplements on iron, zinc and copper status in piglets","volume":"69","author":"Fiesel","year":"2015","journal-title":"Arch. Anim. Nutr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtemb.2014.11.005","article-title":"Effect of phytic acid, tannic acid and pectin on fasting iron bioavailability both in the presence and absence of calcium","volume":"30","author":"Jaramillo","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/09637480903213649","article-title":"Role of oxate, phytate, tannins and cooking on iron bioavailability from foods commonly consumed in Mexico","volume":"61","author":"Sotelo","year":"2010","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_39","first-page":"150","article-title":"The effect of tetracycline administration on iron absorption in mice","volume":"35","author":"Djaldetti","year":"1981","journal-title":"Biomedicine"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lu, P., Sui, M., Zhang, M., Wang, M., Kamiya, T., Okamoto, K., Itoh, H., Okuda, S., Suzuki, M., and Asakura, T. (2021). Rosmarinic Acid and Sodium Citrate Have a Synergistic Bacteriostatic Effect against Vibrio Species by Inhibiting Iron Uptake. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222313010"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Duda-Chodak, A., and Tarko, T. (2023). Possible Side Effects of Polyphenols and Their Interactions with Medicines. Molecules, 28.","DOI":"10.3390\/molecules28062536"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/cpdd.1033","article-title":"Effect of Phosphate Binders and a Dietary Iron Supplement on the Pharmacokinetics of a Single Dose of Vadadustat in Healthy Adults","volume":"11","author":"Paulson","year":"2022","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"20841","DOI":"10.3390\/molecules201119725","article-title":"Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology","volume":"20","author":"Kontoghiorghe","year":"2015","journal-title":"Molecules"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1021\/acs.molpharmaceut.2c00938","article-title":"Oral Non-absorbable Polymer-Deferoxamine Conjugates for Reducing Dietary Iron Absorption","volume":"20","author":"Cui","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0196-0644(97)70073-8","article-title":"Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine\/charcoal slurry","volume":"30","author":"Gomez","year":"1997","journal-title":"Ann. Emerg. Med."},{"key":"ref_46","first-page":"1332","article-title":"Chelators affecting iron absorption in mice","volume":"40","author":"Kontoghiorghes","year":"1990","journal-title":"Arzneimittelforschung"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J., Kolnagou, A., Demetriou, T., Neocleous, M., and Kontoghiorghe, C.N. (2021). New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115546"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2020). Advances on Chelation and Chelator Metal Complexes in Medicine. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072499"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/03630269.2011.578950","article-title":"Interactions of hydroxycarbamide (hydroxyurea) with iron and copper: Implications on toxicity and therapeutic strategies","volume":"35","author":"Konstantinou","year":"2011","journal-title":"Hemoglobin"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.2830420403","article-title":"Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload","volume":"42","author":"Kontoghiorghes","year":"1993","journal-title":"Am. J. Hematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/DDDT.S79458","article-title":"Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes","volume":"10","author":"Kontoghiorghe","year":"2016","journal-title":"Drug Des. Devel Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14740330903535845","article-title":"Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases","volume":"9","author":"Kontoghiorghes","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jnc.12300","article-title":"Deferiprone for the treatment of Friedreich\u2019s ataxia","volume":"126","author":"Pandolfo","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/0883073816636087","article-title":"Clinical Experience With Deferiprone Treatment for Friedreich Ataxia","volume":"31","author":"Glik","year":"2016","journal-title":"J. Child Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1600-0609.2010.01499.x","article-title":"Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone\/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy","volume":"85","author":"Kolnagou","year":"2010","journal-title":"Eur. J. Haematol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1532\/IJH97.E0637","article-title":"Intensive chelation therapy in beta-thalassemia and possible adverse cardiac effects of desferrioxamine","volume":"86","author":"Aessopos","year":"2007","journal-title":"Int. J. Hematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0043-102691","article-title":"Prevention of Iron Overload and Long Term Maintenance of Normal Iron Stores in Thalassaemia Major Patients using Deferiprone or Deferiprone Deferoxamine Combination","volume":"67","author":"Kolnagou","year":"2017","journal-title":"Drug Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/03630269.2010.485890","article-title":"Maintenance of normal range body iron store levels for up to 4.5 years in thalassemia major patients using deferiprone monotherapy","volume":"34","author":"Kolnagou","year":"2010","journal-title":"Hemoglobin"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.2010.08229.x","article-title":"New golden era of chelation therapy in thalassaemia: The achievement and maintenance of normal range body iron stores","volume":"150","author":"Kolnagou","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Kolnagou, A., Kleanthous, M., and Kontoghiorghes, G.J. (2022). Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease. Front. Biosci. (Elite Ed.), 14.","DOI":"10.31083\/j.fbe1403018"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","article-title":"The first 3500 years of aspirin history from its roots\u2014A concise summary","volume":"113","author":"Montinari","year":"2019","journal-title":"Vascul. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/bjh.14520","article-title":"The aspirin story\u2014From willow to wonder drug","volume":"177","author":"Desborough","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.arth.2021.02.007","article-title":"Low-Dose vs. Regular-Dose Aspirin for Venous Thromboembolism Prophylaxis in Primary Total Joint Arthroplasty","volume":"36","author":"Uvodich","year":"2021","journal-title":"J. Arthroplast."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jor.2021.02.005","article-title":"Low dose aspirin is effective in preventing venous thromboembolism in patients undergoing primary total knee arthroplasty","volume":"24","author":"Merkow","year":"2021","journal-title":"J. Orthop."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Chen, Y., Chen, F., Liao, J., Han, H., Li, G., and Zhou, L. (2023). Low- or high-dose preventive aspirin use and risk of death from all-cause, cardiovascular disease, and cancer: A nationally representative cohort study. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1099810"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10787-015-0253-0","article-title":"Efficacy of disintegrating aspirin in two different models for acute mild-to-moderate pain: Sore throat pain and dental pain","volume":"24","author":"Voelker","year":"2016","journal-title":"Inflammopharmacology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2102137","article-title":"ADAPTABLE Team. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease","volume":"384","author":"Jones","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","article-title":"Mode of action of aspirin as a chemopreventive agent","volume":"191","author":"Dovizio","year":"2013","journal-title":"Recent Results Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bph.15966","article-title":"Fifty years with aspirin and platelets","volume":"180","author":"Patrono","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2147\/TCRM.S92222","article-title":"New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism","volume":"11","author":"Mekaj","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Boelig, R.C., Kaushal, G., Rochani, A., McKenzie, S.E., and Kraft, W.K. (2023). Aspirin pharmacokinetics and pharmacodynamics through gestation. Am. J. Obstet. Gynecol.","DOI":"10.1016\/j.ajog.2023.12.028"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Keche, Y., Gaikwad, N.R., Wasnik, P.N., Nagpure, K., Siddiqui, M.S., Joshi, A., Dhaneria, S., Dewangan, G., Meher, J., and Das, P. (2024). Analysis of Drugs Prescribed to Elderly Patients in a Tertiary Health Care Center in Raipur, Central India: An Observational Study. Cureus, 16.","DOI":"10.7759\/cureus.52770"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2147\/DDDT.S409524","article-title":"Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants","volume":"17","author":"Cong","year":"2023","journal-title":"Drug Des. Devel Ther."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Hofling, U., Tacconelli, S., Contursi, A., Bruno, A., Mucci, M., Ballerini, P., Cohen, S., and Patrignani, P. (2022). Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1070277"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Pac\u0142awski, A., Politis, S., Balafas, E., Mina, E., Papakyriakopoulou, P., Christodoulou, E., Kostomitsopoulos, N., Rekkas, D.M., Valsami, G., and Giovagnoli, S. (2022). Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122819"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5414\/CP204271","article-title":"Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet","volume":"60","author":"Atar","year":"2022","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1055\/s-0042-1743469","article-title":"Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities","volume":"122","author":"Bloom","year":"2022","journal-title":"Thromb. Haemost."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41575-020-0325-5","article-title":"Microbiota modulates aspirin chemoprevention in CRC","volume":"17","author":"Ray","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood.2019004596","article-title":"A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia","volume":"136","author":"Rocca","year":"2020","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/00498258609043527","article-title":"The metabolism of aspirin in man: A population study","volume":"16","author":"Hutt","year":"1986","journal-title":"Xenobiotica"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3109\/00498259009046898","article-title":"Comparative metabolism of high doses of aspirin in man and rat","volume":"20","author":"Patel","year":"1990","journal-title":"Xenobiotica"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/M23-0675","article-title":"Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly: A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial","volume":"176","author":"McQuilten","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s40520-019-01454-6","article-title":"Predictors of iron-deficiency anemia in primary care older adults: A real-world European multi-country longitudinal study","volume":"32","author":"Vetrano","year":"2020","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002770050537","article-title":"Iron status in Danes updated 1994. I: Prevalence of iron deficiency and iron overload in 1332 men aged 40-70 years. Influence Of blood donation, alcohol intake, and iron supplementation","volume":"78","author":"Milman","year":"1999","journal-title":"Ann. Hematol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2023). Drug Selection and Posology, Optimal Therapies and Risk\/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316749"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"285S","DOI":"10.1111\/j.1365-2125.1980.tb01811.x","article-title":"Clinical pharmacokinetics of salicylates: A re-assessment","volume":"10","author":"Levy","year":"1980","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000327782","article-title":"Determinants of aspirin metabolism in healthy men and women: Effects of dietary inducers of UDP-glucuronosyltransferases","volume":"4","author":"Navarro","year":"2011","journal-title":"Lifestyle Genom."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0731-7085(98)00081-8","article-title":"Assay of acetylsalicylic acid and three of its metabolites in human plasma and urine using non-aqueous capillary electrophoresis with reversed electroosmotic flow","volume":"17","author":"Hansen","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ajcn\/69.2.318","article-title":"Influence of nutritional status on the pharmacokinetics of acetylsalicylic acid and its metabolites in children with autoimmune disease","volume":"69","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_91","first-page":"527","article-title":"A highly sensitive HPLC method for the simultaneous determination of acetylsalicylic, salicylic and salicyluric acids in biologic fluids: Pharmacokinetic, metabolic and monitoring implications","volume":"18","year":"1996","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpba.2016.12.038","article-title":"Quantitative determination of five metabolites of aspirin by UHPLC-MS\/MS coupled with enzymatic reaction and its application to evaluate the effects of aspirin dosage on the metabolic profile","volume":"138","author":"Li","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejps.2015.03.015","article-title":"Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450","volume":"73","author":"Sedgeman","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_94","first-page":"51","article-title":"Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers","volume":"6","author":"Nagelschmitz","year":"2014","journal-title":"Clin. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Sankaranarayanan, R., Kumar, D.R., Altinoz, M.A., and Bhat, G.J. (2020). Mechanisms of Colorectal Cancer Prevention by Aspirin\u2014A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239018"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Pan, P., Huang, Y.W., Oshima, K., Yearsley, M., Zhang, J., Yu, J., Arnold, M., and Wang, L.S. (2018). Could Aspirin and Diets High in Fiber Act Synergistically to Reduce the Risk of Colon Cancer in Humans?. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010166"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/clpt.1990.147","article-title":"Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one","volume":"48","author":"Kontoghiorghes","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_98","first-page":"65","article-title":"Oral iron chelation therapy with deferiprone. Monitoring of biochemical, drug and iron excretion changes","volume":"45","author":"Kontoghiorghes","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1021\/ja062046j","article-title":"Enterobactin protonation and iron release: Structural characterization of the salicylate coordination shift in ferric enterobactin","volume":"128","author":"Abergel","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref_100","unstructured":"Kontoghiorghes, G.J. (1982). The Design of Orally Active Iron Chelators for the Treatment of Thalassaemia. [Ph.D. Thesis, University of Essex]. Available online: https:\/\/www.pri.ac.cy\/files\/KGJ_thesis_1982.pdf."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jcp.56.9.651","article-title":"Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin","volume":"56","author":"Lawrence","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.1074\/jbc.M109.064618","article-title":"Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors","volume":"285","author":"Cuevas","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0021-9673(01)01098-6","article-title":"Assay of 2,3-dihydroxybenzoic acid and related compounds in plant materials by high-performance liquid chromatography","volume":"927","author":"Muljono","year":"2001","journal-title":"J. Chromatogr. A"},{"key":"ref_104","first-page":"478","article-title":"The development of new iron-chelating drugs","volume":"196","author":"Grady","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.1976.tb03566.x","article-title":"Chelation studies with 2,3-dihydroxybenzoic acid in patients with beta-thalassaemia major","volume":"33","author":"Peterson","year":"1976","journal-title":"Br. J. Haematol."},{"key":"ref_106","first-page":"74","article-title":"Chelation therapy in beta-thalassemia major: A one-year double blind study of 2,3-dihydroxybenzoic acid","volume":"7","author":"Peterson","year":"1979","journal-title":"Exp. Hematol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.1980.tb33682.x","article-title":"Clinical management of thalassemia. The status of new iron chelators","volume":"344","author":"Cerami","year":"1980","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_108","first-page":"27","article-title":"Advances in oral iron chelation in man","volume":"55","author":"Kontoghiorghes","year":"1992","journal-title":"Int. J. Hematol."},{"key":"ref_109","first-page":"570","article-title":"The identification of 2, 3-dihydroxybenzoic acid as a potentially useful iron-chelating drug","volume":"190","author":"Graziano","year":"1974","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_110","first-page":"195","article-title":"Increased synthesis of dihydroxybenzoic acid in the presence of aluminum by Rhizobium MO1","volume":"52","author":"De","year":"2003","journal-title":"Acta Microbiol. Pol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1128\/IAI.71.5.2927-2932.2003","article-title":"Roop RM 2nd. Production of the siderophore 2,3-dihydroxybenzoic acid is required for wild-type growth of Brucella abortus in the presence of erythritol under low-iron conditions in vitro","volume":"71","author":"Bellaire","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0162-0134(00)80251-2","article-title":"Iron mobilization from ferritin by chelating agents","volume":"13","author":"Crichton","year":"1980","journal-title":"J. Inorg. Biochem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.1016\/S0021-9258(17)42756-6","article-title":"Evidence for synergistic anion binding to iron in ovotransferrin complexes from resonance Raman and extended X-ray absorption fine structure analysis","volume":"259","author":"Schneider","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_114","first-page":"2925","article-title":"Comparison of activity of deferoxamine with that of oral iron chelators against human neuroblastoma cell lines","volume":"49","author":"Blatt","year":"1989","journal-title":"Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0020-1693(00)91889-9","article-title":"Structure\/red blood cell permeability. Activity of iron(III) chelator complexes","volume":"151","author":"Kontoghiorghes","year":"1988","journal-title":"Inorg. Chim. Acta"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2141.1976.tb00938.x","article-title":"Inhibition of membrane peroxidation in thalassaemic erythrocytes by 2,3-dihydroxybenzoic acid","volume":"32","author":"Graziano","year":"1976","journal-title":"Br. J. Haematol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1046\/j.1523-1755.2000.00437.x","article-title":"Protection from ototoxicity of intraperitoneal gentamicin in guinea pig","volume":"58","author":"Sinswat","year":"2000","journal-title":"Kidney Int."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10715768609088062","article-title":"In vitro screening of iron chelators using models of free radical damage","volume":"2","author":"Kontoghiorghes","year":"1986","journal-title":"Free Radic. Res. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/bj2370499","article-title":"Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids","volume":"237","author":"Grootveld","year":"1986","journal-title":"Biochem. J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0891-5849(94)00160-L","article-title":"Hydroxyl radical generation in beta-thalassemic red blood cells","volume":"18","author":"Grinberg","year":"1995","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0266-4356(97)90555-6","article-title":"The role of oxygen free radicals in idiopathic facial pain","volume":"35","author":"Aghabeigi","year":"1997","journal-title":"Br. J. Oral. Maxillofac. Surg."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1079\/PNS2005477","article-title":"Is there a role for dietary salicylates in health?","volume":"65","author":"Paterson","year":"2006","journal-title":"Proc. Nutr. Soc."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/jcp.54.7.553","article-title":"Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin","volume":"54","author":"Blacklock","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Dotto, C., Lombarte Serrat, A., Cattelan, N., Barbagelata, M.S., Yantorno, O.M., Sordelli, D.O., Ehling-Schulz, M., Grunert, T., and Buzzola, F.R. (2017). The Active Component of Aspirin, Salicylic Acid, Promotes Staphylococcus aureus Biofilm Formation in a PIA-dependent Manner. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00004"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI19143","article-title":"Salicylic acid: An old dog, new tricks, and staphylococcal disease","volume":"112","author":"Herrmann","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/jocd.16052","article-title":"Efficacy of a multitargeted, salicylic acid-based dermocosmetic cream compared to benzoyl peroxide 5% in Acne vulgaris: Results from a randomized study","volume":"23","author":"Lambert","year":"2024","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0002-8223(21)03743-3","article-title":"Salicylates in foods","volume":"85","author":"Swain","year":"1985","journal-title":"J. Am. Diet Assoc."},{"key":"ref_128","unstructured":"Anderson, F.W., and Hiller, M.C. (1975). Development of Iron Chelators for Clinical Use, DHEW. DHEW Publication No. (NIH) 77-994."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1139\/v70-433","article-title":"Stability constants of three iron(II1) salicylates","volume":"48","author":"McBryde","year":"1970","journal-title":"Can. J. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2116\/analsci.24.1487","article-title":"Simultaneous determination of Fe(III) and Fe(II) ions via complexation with salicylic acid and 1,10-phenanthroline in microcolumn ion chromatography","volume":"24","author":"Oktavia","year":"2008","journal-title":"Anal. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jphotochem.2015.03.018","article-title":"Photochemistry of Fe(III) complexes with salicylic acid derivatives in aqueous solutions","volume":"307","author":"Pozdnyakov","year":"2015","journal-title":"J. Photochem. Photob. A Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/15563650600907140","article-title":"Americal Association of Poison Control Centers; Healthcare Systems Bureau, Health Resources and Sevices Administration, Department of Health and Human Services. Salicylate poisoning: An evidence-based consensus guideline for out-of-hospital management","volume":"45","author":"Chyka","year":"2007","journal-title":"Clin. Toxicol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/bmj.285.6352.1383","article-title":"Diuresis or urinary alkalinisation for salicylate poisoning?","volume":"285","author":"Prescott","year":"1982","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0039-9140(98)00032-0","article-title":"Determination of iron(III) with salicylic acid by the fluorescence quenching method","volume":"46","author":"Cha","year":"1998","journal-title":"Talanta"},{"key":"ref_135","first-page":"807","article-title":"Salicylate attenuates gentamicin-induced ototoxicity","volume":"79","author":"Sha","year":"1999","journal-title":"Lab Investig."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0021-9150(96)06010-8","article-title":"Iron-salicylate complex induces peroxidation, alters hepatic lipid profile and affects plasma lipoprotein composition","volume":"129","author":"Brunet","year":"1997","journal-title":"Atherosclerosis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I\u03baB kinase-\u03b2","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/1055-9965.EPI-10-1135","article-title":"Serum salicylate levels and risk of recurrent colorectal adenomas","volume":"20","author":"Shaukat","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3892\/ijo.2017.4167","article-title":"Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin\u2019s chemopreventive effects against colorectal cancer","volume":"51","author":"Dachineni","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/qjmed\/94.8.445","article-title":"Salicylic acid: A link between aspirin, diet and the prevention of colorectal cancer","volume":"94","author":"Paterson","year":"2001","journal-title":"QJM"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ptr.6573","article-title":"A review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin: Comprehensive pharmacology, toxicology, and some pharmaceutical aspects","volume":"34","author":"Abedi","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.cell.2010.04.040","article-title":"A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production","volume":"141","author":"Devireddy","year":"2010","journal-title":"Cell"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.20132629","article-title":"Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection","volume":"211","author":"Liu","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.2116insight3","article-title":"Microbial hijacking of mammalian iron shuttling","volume":"211","author":"Weiss","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2014.12.010","article-title":"Synthetic, potentiometric and spectroscopic studies of chelation between Fe(III) and 2,5-DHBA supports salicylate-mode of siderophore binding interactions","volume":"145","author":"Porwal","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/1874471012666190916112904","article-title":"Oxidant and Antioxidant Effects of Gentisic Acid in a 177Lu-Labelled Methionine-Containing Minigastrin Analogue","volume":"13","author":"Trindade","year":"2020","journal-title":"Curr. Radiopharm."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Rubira, L., Donz\u00e9, C., Fouillet, J., Algudo, B., Kotzki, P.O., Deshayes, E., and Fersing, C. (2024). [68Ga]Ga-FAPI-46 synthesis on a GAIA\u00ae module system: Thorough study of the automated radiolabeling reaction conditions. Appl. Radiat. Isot., 206.","DOI":"10.1016\/j.apradiso.2024.111211"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1042\/bj2760753","article-title":"Hydroxylation of salicylate by microsomal fractions and cytochrome P-450. Lack of production of 2,3-dihydroxybenzoate unless hydroxyl radical formation is permitted","volume":"276","author":"Kaur","year":"1991","journal-title":"Biochem. J."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Arreguin MLGonz\u00e1lez, A.G., P\u00e9rez-Almeida, N., Arnone, V., Gonz\u00e1lez-D\u00e1vila, M., and Santana-Casiano, J.M. (2021). The role of gentisic acid on the Fe(III) redox chemistry in marine environments. Mar. Chem., 234.","DOI":"10.1016\/j.marchem.2021.104003"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jps.3030430118","article-title":"A comparison of the determination of gentisic acid in blood by means of the ferric ion-gentisate complex with and without the presence of ferrous ions","volume":"43","author":"Cass","year":"1954","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1021\/jf202561p","article-title":"Structure and function of the oxidation products of polyphenols and identification of potent lipoxygenase inhibitors from Fe-catalyzed oxidation of resveratrol","volume":"59","author":"Shingai","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-5793(00)01289-8","article-title":"The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein","volume":"470","author":"Exner","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"14820","DOI":"10.1007\/s11356-015-4717-y","article-title":"Phenolic profile of Dunaliella tertiolecta growing under high levels of copper and iron","volume":"22","author":"Rico","year":"2015","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Saeedavi, M., Goudarzi, M., Fatemi, I., Basir, Z., Noori, S.M.A., and Mehrzadi, S. (2023). Gentisic acid mitigates gentamicin-induced nephrotoxicity in rats. Tissue Cell, 84.","DOI":"10.1016\/j.tice.2023.102191"},{"key":"ref_155","first-page":"1409","article-title":"Hepatoprotective effects of gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice","volume":"26","author":"Harooni","year":"2023","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/10715762.2011.633518","article-title":"Antioxidant activity and free radical scavenging reactions of gentisic acid: In-vitro and pulse radiolysis studies","volume":"46","author":"Joshi","year":"2012","journal-title":"Free Radic. Res."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Hang, D.T.N., Hoa, N.T., Bich, H.N., Mechler, A., and Vo, Q.V. (2022). The hydroperoxyl radical scavenging activity of natural hydroxybenzoic acids in oil and aqueous environments: Insights into the mechanism and kinetics. Phytochemistry, 201.","DOI":"10.1016\/j.phytochem.2022.113281"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Liu, G., Zhu, W., Li, S., Zhou, W., Zhang, H., Wang, J., Liu, X., Zhang, J., Liang, L., and Xu, X. (2021). Antioxidant capacity and interaction of endogenous phenolic compounds from tea seed oil. Food Chem., 376.","DOI":"10.1016\/j.foodchem.2021.131940"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cbi.2018.05.016","article-title":"From epidemiology to treatment: Aspirin\u2019s prevention of brain and breast-cancer and cardioprotection may associate with its metabolite gentisic acid","volume":"291","author":"Altinoz","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.toxlet.2004.04.048","article-title":"Modulatory effect of gentisic acid on the augmentation of biochemical events of tumor promotion stage by benzoyl peroxide and ultraviolet radiation in Swiss albino mice","volume":"153","author":"Sharma","year":"2004","journal-title":"Toxicol. Lett."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00008469-200402000-00009","article-title":"Study on prevention of two-stage skin carcinogenesis by Hibiscus rosa sinensis extract and the role of its chemical constituent, gentisic acid, in the inhibition of tumour promotion response and oxidative stress in mice","volume":"13","author":"Sharma","year":"2004","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2125.1989.tb03526.x","article-title":"Salicylate pharmacokinetics in patients with rheumatoid arthritis","volume":"28","author":"Owen","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00542188","article-title":"Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis","volume":"32","author":"Bochner","year":"1987","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1258\/0004563021901739","article-title":"Identification and determination of salicylic acid and salicyluric acid in urine of people not taking salicylate drugs","volume":"39","author":"Baxter","year":"2002","journal-title":"Ann. Clin. Biochem."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Park, M.V. (1966). Complex formation between iron (III) and some substituted salicylic acids. Chem. Soc. A, 816\u2013820.","DOI":"10.1039\/j19660000816"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0277-5387(00)83443-9","article-title":"Complex formation between transition metal ions and salicylglycine, a metabolite of aspirin","volume":"13","author":"Gonzalez","year":"1994","journal-title":"Polyhedron"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jps.3030490702","article-title":"The avidity of salicylic, gentisic, and salicyluric acids for heavy metal cations","volume":"49","author":"Pecci","year":"1960","journal-title":"J. Am. Pharm. Assoc. Am. Pharm. Assoc. (Sci. Ed.)"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0020-1693(95)04786-7","article-title":"Coordination of 2-hydroxyhippuric acid to the copper(II) ion: A solution and solid state study","volume":"244","author":"Bavoso","year":"1996","journal-title":"Inorg. Chim. Acta"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jinorgbio.2003.11.002","article-title":"Model complexes with naturally occurring ligands (salicylglycine and imidazol) and the biometals copper and cobalt","volume":"98","author":"Ferrer","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0162-0134(00)00179-3","article-title":"Potentiometric and spectroscopic studies on the dimethyltin(IV) complexes of 2-hydroxyhippuric acid","volume":"83","author":"Gajda","year":"2001","journal-title":"J. Inorg. Biochem."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1021\/ic1003066","article-title":"Terbium-macrocycle complexes as chemical sensors: Detection of an aspirin metabolite in urine using a salicylurate-specific receptor site","volume":"49","author":"Esplin","year":"2010","journal-title":"Inorg. Chem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1208\/s12249-015-0316-y","article-title":"A Reaction of Aspirin with Ferrous Gluconate","volume":"16","author":"Zhang","year":"2015","journal-title":"AAPS PharmSciTech."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-5793(97)01307-0","article-title":"Aspirin protects endothelial cells from oxidative stress\u2014Possible synergism with vitamin E","volume":"417","author":"Podhaisky","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI113289","article-title":"Iron chelation as a possible mechanism for aspirin-induced malondialdehyde production by mouse liver microsomes and mitochondria","volume":"81","author":"Schwarz","year":"1988","journal-title":"J. Clin. Investig."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0891-5849(90)90004-3","article-title":"Antioxidant characteristics of some potential anticataract agents. Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract","volume":"9","author":"Woollard","year":"1990","journal-title":"Free Radic. Biol. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/00498258809041682","article-title":"The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs","volume":"18","author":"Aruoma","year":"1988","journal-title":"Xenobiotica"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuint.2015.10.014","article-title":"Effects of aspirin on expression of iron transport and storage proteins in BV-2 microglial cells","volume":"91","author":"Xu","year":"2015","journal-title":"Neurochem. Int."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.RES.82.9.1016","article-title":"Aspirin increases ferritin synthesis in endothelial cells: A novel antioxidant pathway","volume":"82","author":"Oberle","year":"1998","journal-title":"Circ. Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: Process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/cmdc.202100334","article-title":"Autophagy-Dependent Ferroptosis as a Therapeutic Target in Cancer","volume":"16","author":"Liu","year":"2021","journal-title":"Chemmedchem"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: Opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2022). New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213990"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Wu, Z., Li, D., Tian, D., Liu, X., and Wu, Z. (2022). Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0279010"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41419-023-06144-w","article-title":"Emerging significance and therapeutic targets of ferroptosis: A potential avenue for human kidney diseases","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41420-024-01863-1","article-title":"Ferroptosis: A new hunter of hepatocellular carcinoma","volume":"10","author":"Jiang","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Cheng, X., Zhao, F., Ke, B., Chen, D., and Liu, F. (2023). Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches. Cancers, 15.","DOI":"10.3390\/cancers15215209"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Li, B., Yang, L., Peng, X., Fan, Q., Wei, S., Yang, S., Li, X., Jin, H., Wu, B., and Huang, M. (2020). Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers. Biomed. Pharmacother., 130.","DOI":"10.1016\/j.biopha.2020.110710"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Zhu, X., and Li, S. (2023). Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance. Adv. Sci., 10.","DOI":"10.1002\/advs.202300824"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/15384047.2022.2104561","article-title":"Colorectal cancer chemoprevention: Is aspirin still in the game?","volume":"23","author":"Grancher","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Chen, H., Qi, Q., Wu, N., Wang, Y., Feng, Q., Jin, R., and Jiang, L. (2022). Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR\/SREBP-1\/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. Redox Biol., 55.","DOI":"10.1016\/j.redox.2022.102426"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41401-023-01062-1","article-title":"Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-\u03baB p65-activated SLC7A11 transcription","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1021\/jm101019j","article-title":"Synthesis and biological activities of transition metal complexes based on acetylsalicylic acid as neo-anticancer agents","volume":"53","author":"Rubner","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/clpt.1989.21","article-title":"Ferrous sulfate reduces levodopa bioavailability: Chelation as a possible mechanism","volume":"45","author":"Campbell","year":"1989","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2125.1992.tb04010.x","article-title":"Norfloxacin interaction with antacids and minerals","volume":"33","author":"Campbell","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2125.1998.t01-1-00794.x","article-title":"Ferrous sulphate interacts with captopril","volume":"46","author":"Schaefer","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_199","first-page":"754","article-title":"In vitro studies on interactions of iron salts and complexes with food-stuffs and medicaments","volume":"40","author":"Geisser","year":"1990","journal-title":"Arzneimittelforschung"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003088-199835060-00002","article-title":"Clinical pharmacokinetics of oxaprozin","volume":"35","author":"Davies","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-199834020-00002","article-title":"Clinical pharmacokinetics of ibuprofen. The first 30 years","volume":"34","author":"Davies","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.clinthera.2012.11.002","article-title":"Clinical impact of drug-drug interaction between aspirin and prednisolone at a cancer center","volume":"34","author":"Koomanan","year":"2012","journal-title":"Clin. Ther."},{"key":"ref_203","first-page":"197","article-title":"Interaction between ascorbic acid and acetylsalicylic acid and their effects on nutritional status in man","volume":"55","author":"Johansson","year":"1985","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"86","DOI":"10.17344\/acsi.2022.7796","article-title":"Determination of Copper at Extended Dose Levels of Copper (II)-acetylsalicylate and Pharmacokinetics Applications","volume":"70","author":"Sher","year":"2023","journal-title":"Acta Chim. Slov."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.chom.2023.12.015","article-title":"A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage","volume":"32","author":"Li","year":"2024","journal-title":"Cell Host Microbe"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ehf2.13818","article-title":"Prevalence and determinants of iron deficiency in cardiac amyloidosis","volume":"9","author":"Moutereau","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_207","first-page":"22","article-title":"Iron status in the elderly","volume":"136\u2013137","author":"Wawer","year":"2014","journal-title":"Mech. Ageing Dev."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jnci\/djn209","article-title":"Decreased cancer risk after iron reduction in patients with peripheral arterial disease: Results from a randomized trial","volume":"100","author":"Zacharski","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer:analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0140-6736(11)60667-3","article-title":"Aspirin in the prevention of cancer","volume":"377","author":"Mascitelli","year":"2011","journal-title":"Lancet"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.dld.2017.12.023","article-title":"Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)","volume":"50","author":"Michel","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.122.001631","article-title":"Cyclooxygenase Inhibitors and Cancer: The Missing Pieces","volume":"386","author":"Patrono","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1182\/blood.2019003977","article-title":"Aspirin and antiplatelet treatments in cancer","volume":"137","author":"Tao","year":"2021","journal-title":"Blood"},{"key":"ref_214","first-page":"91","article-title":"An intracellular transit iron pool","volume":"51","author":"Jacobs","year":"1976","journal-title":"Ciba Found. Symp."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/ejh.13244","article-title":"Deferiprone exerts a dose-dependent reduction of liver iron in adults with iron overload","volume":"103","author":"Binding","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood.V79.10.2741.bloodjournal79102741","article-title":"Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia","volume":"79","author":"Olivieri","year":"1992","journal-title":"Blood"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(87)90545-9","article-title":"1,2-Dimethyl-3-Hydroxypyrid-4-One, an Orally Active Chelator for Treatment of Iron Overload","volume":"329","author":"Kontoghiorghes","year":"1987","journal-title":"Lancet"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/bmj.295.6612.1509","article-title":"Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one","volume":"295","author":"Kontoghiorghes","year":"1987","journal-title":"BMJ"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: Analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.21037\/atm.2019.07.52","article-title":"The dilemma of aspirin resistance in obese patients","volume":"7","author":"Ardeshna","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population","volume":"26","author":"Cuzick","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2023). Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054970"},{"key":"ref_223","first-page":"659","article-title":"Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals","volume":"43","author":"Sheppard","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0306-9877(98)90024-X","article-title":"A chelate theory for the mechanism of action of aspirin-like drugs","volume":"50","author":"Wang","year":"1998","journal-title":"Med. Hypotheses"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-0609.1986.tb02282.x","article-title":"Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA)","volume":"36","author":"Pippard","year":"1986","journal-title":"Scand. J. Haematol."},{"key":"ref_226","first-page":"161","article-title":"Prospects for introducing deferiprone as potent pharmaceutical antioxidant","volume":"1","author":"Kontoghiorghes","year":"2009","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-5793(89)80201-7","article-title":"Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity","volume":"245","author":"Barradas","year":"1989","journal-title":"FEBS Lett."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/bj2540239","article-title":"The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro","volume":"254","author":"Jeremy","year":"1988","journal-title":"Biochem. J."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Derry, S., and Loke, Y.K. (2000). Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis. BMJ, 321.","DOI":"10.1136\/bmj.321.7270.1183"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/pr.2018.44","article-title":"Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease","volume":"83","author":"Migally","year":"2018","journal-title":"Pediatr. Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000065685","article-title":"Effect of increasing doses of aspirin on platelet aggregation among stroke patients","volume":"14","author":"Gan","year":"2002","journal-title":"Cerebrovasc. Dis."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002826-199312000-00002","article-title":"Low- versus high-dose aspirin in prevention of ischemic stroke","volume":"16","author":"Adams","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/15376516.2012.730562","article-title":"EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: Review of preliminary findings and risk\/benefit assessment","volume":"23","author":"Born","year":"2013","journal-title":"Toxicol. Mech. Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/10\/5150\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:42:34Z","timestamp":1760107354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/10\/5150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":234,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["ijms25105150"],"URL":"https:\/\/doi.org\/10.3390\/ijms25105150","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}